FEATURED/ARCHIVES (20/05/24)
Cost-Effectiveness of Long-Acting Risperidone Injection versus Alternative Atypical Antipsychotic Agents in Patients with Schizophrenia in China · November 2009
Articles
Value in Health
Factors Associated with Direct Health Care Costs in Schizophrenia: Results from the FACE-SZ French Dataset · January 2018
Articles
European Neuropsychopharmacology
Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial · October 2015
Articles
PLOS ONE
Cost-Effectiveness Analysis of Ziprasidone versus Haloperidol in Sequential Intramuscular/Oral Treatment of Exacerbation of Schizophrenia: Economic Subanalysis of the ZIMO Trial (NHS Economic Evaluation Database) · September 2007
Abstracts
University of York>Clinical Drug Investigation
Pharmaco-Utilisation and Related Costs of Drugs Used to Treat Schizophrenia and Bipolar Disorder in Italy: The IBIS Study · October 2014
Articles
BMC Psychiatry
Pharmacotherapy and Health Care Costs among Patients with Schizophrenia and Newly Diagnosed Diabetes · July 2005
Articles
Psychiatric Services
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder · February 2013
Articles (Manuscripts-Versions)
PubMed Central>American Journal of Managed Care
Antipsychotic Adherence, Resource Use, and Costs Before and After the Initiation of Once-Monthly Paliperidone Palmitate Therapy among Medicaid Beneficiaries with Prior Schizophrenia Relapse · February 2021
Abstracts
Clinical Therapeutics
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR · July 2020
Articles
Clinical Drug Investigation
Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population · July 2009
Articles
Value in Health
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate vs. Haloperidol Decanoate in Maintenance Treatment of Schizophrenia · June 2016
Articles
Psychiatric Services
Comparison of Discharge Rates and Drug Costs for Patients with Schizophrenia Treated with Risperidone or Olanzapine · May 2001
Articles
Psychiatric Services
Health Care Resource Use and Direct Medical Costs for Patients with Schizophrenia in Tianjin, People’s Republic of China · April 2015
Articles
Neuropsychiatric Disease and Treatment
A Decision Model to Compare Health Care Costs of Olanzapine and Risperidone Treatment of Schizophrenia in Germany (NHS Economic Evaluation Database) · September 2006
Abstracts
University of York>European Journal of Health Economics
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia · June 2007
Articles
Schizophrenia Bulletin
Changing Environments and Alternative Perspectives in Evaluating the Cost-Effectiveness of New Antipsychotic Drugs · January 2003
Articles
Schizophrenia Bulletin
Evaluating the Cost and Clinical Effectiveness of Long-Acting, Injectable Aripiprazole and Paliperidone Palmitate Once a Month in a Real-World Setting · August 2019
Articles
ClinicoEconomics and Outcomes Research
Cost Comparison of Atypical Antipsychotics: Paliperidone ER and Risperidone · November 2018
Articles
NCBI>Hospital Pharmacy
Long-Term Cost-Effectiveness of Atypical Antipsychotics in the Treatment of Adults with Schizophrenia in the US · September 2013
Articles
ClinicoEconomics and Outcomes Research
Predicting Future High-Cost Schizophrenia Patients Using High-Dimensional Administrative Data · June 2017
Articles
Frontiers in Psychiatry